Initial appetite control and energy improvements may be observed within 1-2 weeks, while noticeable weight loss and improved glucose control often occur within 4-8 weeks
Quercetin may help prevent lipid formation and inflammation, both of which can contribute to heart disease
Distribution channels and key stakeholders Large wholesalers such as McKesson in Canada, serve closely aligned, and at times outright owned, retail pharmacy networks
Expanded Approval for Pediatrics With rising rates of diabetes and excess weight in children, the FDA has expanded the use of incretin-based therapies to younger populations
Limited tirzepatide data: A 2026 study gave 11 lactating women a single 5 mg dose of tirzepatide, the active ingredient in Mounjaro and Zepbound
It will not produce appetite suppression comparable to GLP-1 medications, but it may help reduce the specific pull toward sweet foods